Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 188

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 188
---
 has been amended to reflect such restatement or Enfusion or its independent auditor has, as applicable, announced or informed Clearwater that it has
concluded that no restatement will be required. The Marketing Period will end on any earlier date prior to the expiration of the 17 consecutive business day period described above if the debt financing is actually funded on such earlier date.

For purposes of this Proxy Statement/Prospectus and the Merger Agreement, “” means
(A) the consolidated financial statements of Enfusion and its subsidiaries included in its Annual Report on Form 10-K for the year ending December 31, 2024, and (B) to the extent reasonably
requested in writing by Clearwater and readily available or in the possession of the Enfusion and its subsidiaries, such financial and related information regarding Enfusion and its subsidiaries, in each case, together with customary authorization
and representation letters duly executed on behalf of Enfusion and/or its subsidiaries with respect to

116

such information, as is necessary to permit Clearwater to prepare a customary “public side” and “private side” bank book regarding the business of Enfusion and its
subsidiaries, in each case, to the extent required for the Debt Financing and required by the Debt Commitment Letter.

Organizational Documents; Directors and Officers

From and after the LLC Merger Effective Time, the Surviving LLC will possess all rights, privileges, immunities, powers and franchises of
Enfusion OpCo, and all debts, liabilities and duties of Enfusion OpCo and Merger Sub II will become the debts, liabilities and duties of the Surviving LLC. From and after the Effective Time, the Surviving Corporation will possess all rights,
privileges, immunities, powers and franchises of Enfusion, and all debts, liabilities and duties of Enfusion and Merger Sub will become the debts, liabilities and duties of the Surviving Corporation. From and after the Second Effective Time (if the
Second Effective Time occurs in accordance with the terms and conditions of the Merger Agreement), the Second Surviving Corporation will possess all rights, privileges, immunities, powers and franchises of the Surviving Corporation, and all debts,
liabilities and duties of the Surviving Corporation and Acquirer will become the debts, liabilities and duties of the Second Surviving Corporation.

At the LLC Merger Effective Time, by virtue of the LLC Merger, (a) the certificate of formation of Enfusion OpCo, as in effect
immediately prior to the LLC Merger